Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 October 2023 | Story André Damons | Photo André Damons
Prof Mathys Labuschagne
Prof Chris Viljoen, Head of the School of Biomedical Sciences; Prof Gert van Zyl, Dean of the Faculty of Health Sciences; Prof Francis Petersen, UFS Vice-Chancellor and Principal; and Prof Mathys Labuschagne, Head of the Clinical Simulation and Skills Unit (CSSU), during the unit’s 10-year anniversary celebration.

In just 10 years, the Clinical Simulation and Skills Unit (CSSU) at the University of the Free State (UFS) went from being just a dream to becoming a national and international leader in medical simulation training.

The CSSU forms part of the School of Biomedical Sciences and was officially opened on 21 February 2013. The CSSU celebrated its 10-year anniversary on Thursday, 12 October 2023.

Prof Mathys Labuschagne, Head of the CSSU, said at the evening’s celebration that the vision and dream came true 10 years ago. “I think the requirement for the successful integration of simulation into a curriculum is first and foremost that it is based on research evidence. It is not a thumb-sucking exercise”.

“It is really seated in research and then you need passion and dedication. You cannot be successful without that, and for that I need to thank my staff – without your passion and dedication it would not be possible to excel,” said Prof Labuschagne.

Simulation important for patient safety

According to the professor, good networking is also important – between departments, professions and companies outside the university and hospital. He said simulation is important for improving patient safety and expanding the training platform.

“By doing simulation, we can train students who cannot always be accommodated on the training platform. There are also a lot of educational advantages to using simulation. Our training activities in the past 10 years grew tremendously. At the moment we have about 4000 undergraduate and postgraduate student contacts a year. Then we do a lot of certification and Continuing Professional Development (CPD) courses. During COVID-19 we did PPE training and ICU training for hospital and clinical staff in a safe environment.

“I am really proud of our research output. In the past 10 years we published 34 articles, and have another six articles currently in press. We have successfully completed eight master’s and seven PhD dissertations and there are now five students who are enrolled and all of them are simulation-associated. I cannot believe it has already been 10 years. I am very proud of the unit, and we strive for excellence in simulation education and training.”

Highlights of unit

Prof Gert van Zyl, Dean of the UFS Faculty of Health Sciences, congratulated the unit on achieving this milestone. Taking a trip down memory lane, he mentioned the names of colleagues who played a role in establishing the unit and said their contributions might not be visible in name in the unit, but they are recognised by them in achieving this milestone.

“It is an excellent achievement to have seven PhDs in 10 years. Well done. Another highlight is supporting the establishing of other simulation units at Nelson Mandela University who came to learn from us. They didn’t have to go the US. The training of staff and students during COVID-19, we had the facility. Let us not forget our simulation role at undergraduate and postgraduate training.

Cutting edge of simulation-based education and training

Prof Francis Petersen, UFS Vice-Chancellor and Principal, who gave a toast at the celebration, said the occasion is an opportunity to reflect on the excellent work done over the past decade and to consider how the unit is ideally placed to meet the aspirations that the UFS has for Vision 130 and the strategy of the university.

“The work of this unit has put the University of the Free State at the cutting edge of simulation-based education and training and the ongoing efforts of all of our staff in the unit who assist with the planning, the development, the setup, and the running of scenarios are acknowledged and greatly appreciated. I want to congratulate the leadership and the staff of the unit for the excellent work you are doing,” said Prof Petersen.

According to him, simulation education has numerous advantages such as improved patient safety, skills development, learning without involving real patients and the transfer of knowledge to the clinical environment. It creates a well-structured teaching and learning framework where simulation can be used as an educational tool assist in grasping the practical aspects of learning.

The training of specialised skills and deliberate practice are the key drivers behind clinical simulation as a training technique. It can also be applied as a tool to prepare students for a crisis situation, which requires high levels of preparedness and that is a very important aspect, said Prof Petersen.

“All these aspects of simulation-based education are something that relates very much to our vision and strategy. We want to be a research-led university, which means that it is not only doing research, but we try to focus on evidence and the research also helps us in the undergraduate programme to make it much more competitive.

“It also brings to the fore some qualities of our values, value of quality, value of impact and value of care. In addition, clinical simulation creates a vibrant learning experience for students and contributes towards our goal to meet the highest standards of excellence and impact in our teaching, learning and research.”

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept